Bookmark Article
A new study published in NEJM Evidence suggests that ulipristal acetate, the active ingredient in the contraceptive Ella, could be a potential substitute for the abortion pill mifepristone. The study involved 133 women who took a higher dose of ulipristal acetate followed by misoprostol, resulting in a 97 percent completion rate for terminating pregnancies. The findings have raised concerns about blurring the line between emergency contraception and abortion, potentially impacting the politics surrounding reproductive health.
Full Article
